ÂÜÀòÂÒÂ×

Dr. Vladimir Trubetskoy holds a Master’s degree in Polymer Chemistry from Moscow State University and PhD in Biochemistry from the National Cardiology Research Center in Moscow, Russia. He completed his postdoctoral training at the Dept of Biochemistry at the University of Tennessee and the Center for Imaging and Pharmaceutical Research at Massachusetts General Hospital, Harvard Medical School. Dr. Trubetskoy joined Mirus Corporation in 1996 where he was involved in design of polymer-based systems for nucleic acid delivery. Mirus Corporation was acquired by Roche in 2008 and became Arrowhead Pharmaceuticals in 201 where he remained until 2015. He is a co-author of 38 original research papers, 9 reviews/book chapters and co-inventor on 33 US patents.